# Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema

> **NCT02556424** · PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 114 (actual)

## Conditions studied

- Inflammatory Macular Edema

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Triamcinolone

## Key facts

- **NCT ID:** NCT02556424
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2021-02-15
- **Final completion:** 2021-02-15
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02556424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02556424, "Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02556424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*